Human Immunodeficiency Virus Type 1 Envelope Gp120 is Cleaved After Incubation with Recombinant Soluble CD4

Overview

Journal J Virol

Publisher American Society for Microbiology

Date 1993 May 1

PMID 8474162

Citations 19

Authors

A Werner

J A Levy

Affiliations

Soon will be listed here.

Abstract

Human immunodeficiency virus type 1 (HIV-1) infects human CD4+ cells by a high-affinity interaction between its envelope glycoprotein gp120 and the CD4 molecule on the cell surface. Subsequent virus entry into the cells involves other steps, one of which could be cleavage of the gp120 followed by virus-cell fusion. The envelope gp120 is highly variable among different HIV-1 isolates, but conserved amino acid sequence motifs that contain potential proteolytic cleavage sites can be found. Following incubation with a soluble form of CD4, we demonstrate that gp120 of highly purified HIV-1 preparations is, without addition of exogenous proteinase, cleaved most likely in the V3 loop, yielding two proteins of 50 and 70 kDa. The extent of gp120 proteolysis is HIV-1 strain dependent and correlates with the recombinant soluble CD4 sensitivity to neutralization of the particular strain. The origin of the proteolytic activity in the virus preparations remains unclear. The results support the hypothesis that cleavage of gp120 is required for HIV infection of cells.

Citing Articles

Identification and CRISPR/Cas9 Inactivation of the C1s Protease Responsible for Proteolysis of Recombinant Proteins Produced in CHO Cells.

Li S, Yu B, Byrne G, Wright M, ORourke S, Mesa K Biotechnol Bioeng. 2019; 116(9):2130-2145.

PMID: 31087560 PMC: 6675663. DOI: 10.1002/bit.27016.

Trimeric HIV Env provides epitope occlusion mediated by hypervariable loops.

Moscoso C, Xing L, Hui J, Hu J, Kalkhoran M, Yenigun O Sci Rep. 2014; 4:7025.

PMID: 25395053 PMC: 4231788. DOI: 10.1038/srep07025.

Structural analysis of a highly glycosylated and unliganded gp120-based antigen using mass spectrometry.

Wang L, Qin Y, Ilchenko S, Bohon J, Shi W, Cho M Biochemistry. 2010; 49(42):9032-45.

PMID: 20825246 PMC: 2957511. DOI: 10.1021/bi1011332.

A V3 loop-dependent gp120 element disrupted by CD4 binding stabilizes the human immunodeficiency virus envelope glycoprotein trimer.

Xiang S, Finzi A, Pacheco B, Alexander K, Yuan W, Rizzuto C J Virol. 2010; 84(7):3147-61.

PMID: 20089638 PMC: 2838131. DOI: 10.1128/JVI.02587-09.

Characterization of the multiple conformational States of free monomeric and trimeric human immunodeficiency virus envelope glycoproteins after fixation by cross-linker.

Yuan W, Bazick J, Sodroski J J Virol. 2006; 80(14):6725-37.

PMID: 16809278 PMC: 1489074. DOI: 10.1128/JVI.00118-06.

References

Luciw P, Potter S, Steimer K, Dina D, Levy J . Molecular cloning of AIDS-associated retrovirus. Nature. 1984; 312(5996):760-3. DOI: 10.1038/312760a0. View

McKeating J, McKnight A, Moore J . Differential loss of envelope glycoprotein gp120 from virions of human immunodeficiency virus type 1 isolates: effects on infectivity and neutralization. J Virol. 1991; 65(2):852-60. PMC: 239825. DOI: 10.1128/JVI.65.2.852-860.1991. View

Klatzmann D, Champagne E, Chamaret S, Gruest J, Guetard D, Hercend T . T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature. 1984; 312(5996):767-8. DOI: 10.1038/312767a0. View

Power M, Barr P, Steimer K, Stempien M, Gee W, Renard A . Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-2). Science. 1985; 227(4686):484-92. DOI: 10.1126/science.2578227. View

Hoffman A, Banapour B, Levy J . Characterization of the AIDS-associated retrovirus reverse transcriptase and optimal conditions for its detection in virions. Virology. 1985; 147(2):326-35. DOI: 10.1016/0042-6822(85)90135-7. View

Kikukawa R, Koyanagi Y, Harada S, Kobayashi N, Hatanaka M, Yamamoto N . Differential susceptibility to the acquired immunodeficiency syndrome retrovirus in cloned cells of human leukemic T-cell line Molt-4. J Virol. 1986; 57(3):1159-62. PMC: 252852. DOI: 10.1128/JVI.57.3.1159-1162.1986. View

Levy J, Cheng-Mayer C, Dina D, Luciw P . AIDS retrovirus (ARV-2) clone replicates in transfected human and animal fibroblasts. Science. 1986; 232(4753):998-1001. DOI: 10.1126/science.3010461. View

McDougal J, Nicholson J, Cross G, Cort S, Kennedy M, Mawle A . Binding of the human retrovirus HTLV-III/LAV/ARV/HIV to the CD4 (T4) molecule: conformation dependence, epitope mapping, antibody inhibition, and potential for idiotypic mimicry. J Immunol. 1986; 137(9):2937-44. View

Lifson J, Feinberg M, Reyes G, Rabin L, Banapour B, Chakrabarti S . Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein. Nature. 1986; 323(6090):725-8. DOI: 10.1038/323725a0. View

10.

Putney S, Matthews T, Robey W, Lynn D, Robert-Guroff M, Mueller W . HTLV-III/LAV-neutralizing antibodies to an E. coli-produced fragment of the virus envelope. Science. 1986; 234(4782):1392-5. DOI: 10.1126/science.2431482. View

11.

Gelderblom H, Hausmann E, Ozel M, Pauli G, Koch M . Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins. Virology. 1987; 156(1):171-6. DOI: 10.1016/0042-6822(87)90449-1. View

12.

Pan L, Cheng-Mayer C, Levy J . Patterns of antibody response in individuals infected with the human immunodeficiency virus. J Infect Dis. 1987; 155(4):626-32. DOI: 10.1093/infdis/155.4.626. View

13.

Evans L, McHugh T, Stites D, Levy J . Differential ability of human immunodeficiency virus isolates to productively infect human cells. J Immunol. 1987; 138(10):3415-8. View

14.

Cheng-Mayer C, Rutka J, Rosenblum M, McHugh T, Stites D, Levy J . Human immunodeficiency virus can productively infect cultured human glial cells. Proc Natl Acad Sci U S A. 1987; 84(10):3526-30. PMC: 304904. DOI: 10.1073/pnas.84.10.3526. View

15.

Stein B, Gowda S, Lifson J, Penhallow R, Bensch K, Engleman E . pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane. Cell. 1987; 49(5):659-68. DOI: 10.1016/0092-8674(87)90542-3. View

16.

Murakami T, Hattori T, Takatsuki K . A principal neutralizing domain of human immunodeficiency virus type 1 interacts with proteinase-like molecule(s) at the surface of Molt-4 clone 8 cells. Biochim Biophys Acta. 1991; 1079(3):279-84. DOI: 10.1016/0167-4838(91)90070-g. View

17.

Chesebro B, Nishio J, Perryman S, Cann A, OBrien W, Chen I . Identification of human immunodeficiency virus envelope gene sequences influencing viral entry into CD4-positive HeLa cells, T-leukemia cells, and macrophages. J Virol. 1991; 65(11):5782-9. PMC: 250239. DOI: 10.1128/JVI.65.11.5782-5789.1991. View

18.

Cheng-Mayer C, Shioda T, Levy J . Host range, replicative, and cytopathic properties of human immunodeficiency virus type 1 are determined by very few amino acid changes in tat and gp120. J Virol. 1991; 65(12):6931-41. PMC: 250799. DOI: 10.1128/JVI.65.12.6931-6941.1991. View

19.

Moore J, McKeating J, Huang Y, Ashkenazi A, Ho D . Virions of primary human immunodeficiency virus type 1 isolates resistant to soluble CD4 (sCD4) neutralization differ in sCD4 binding and glycoprotein gp120 retention from sCD4-sensitive isolates. J Virol. 1992; 66(1):235-43. PMC: 238280. DOI: 10.1128/JVI.66.1.235-243.1992. View

20.

Barnett S, Quiroga M, Werner A, Dina D, Levy J . Distinguishing features of an infectious molecular clone of the highly divergent and noncytopathic human immunodeficiency virus type 2 UC1 strain. J Virol. 1993; 67(2):1006-14. PMC: 237455. DOI: 10.1128/JVI.67.2.1006-1014.1993. View